All posts tagged "Israeli company wins $ 28.5 million for restorative cystic fibrosis treatment"

Israeli company wins $ 28.5 million for restorative cystic fibrosis treatment

Jerusalem-based SpliSense, with a focus on cystic fibrosis and other hereditary lung diseases Closed In a $ 28.5 million Series B funding round.Participated in the round...